Jose H. Flores‐Arredondo
Jose H. Flores‐Arredondo publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Cardiac Fibrosis and Remodeling, Lipoproteins and Cardiovascular Health and Viral Infections and Immunology Research.
- World rank
- #2,182,003 of 7,710,434 ranked researchers
- Rank in United States
- #655,456 of 1,627,098
- Works
- 32
- Citations
- 1.1k
- Citations per work
- 34.4
What does Jose H. Flores‐Arredondo research?
Jose H. Flores‐Arredondo's work is mostly in Medicine (51%), Engineering (7%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1651.1%
- Medicine1651.1%
- Everything else1133.1%
- Life Sciences39.0%
- Physical Sciences26.8%
- Engineering26.8%
- 1Cardiology and Cardiovascular Medicine30% of their works
- 2Surgery15% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Biomedical Engineering7% of their works
- 5Molecular Biology4% of their works
- 6Immunology4% of their works
Research topics
- Cardiac Fibrosis and Remodeling
- Lipoproteins and Cardiovascular Health
- Viral Infections and Immunology Research
- Atherosclerosis and Cardiovascular Diseases
- Cardiac pacing and defibrillation studies
- Monoclonal and Polyclonal Antibodies Research
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
Which keywords describe Jose H. Flores‐Arredondo's research?
The keywords of their largest research topics: Heart Failure, Cytokines, Myocardial Infarction, Cardiac Remodeling, Inflammatory Response, Cholesterol-lowering, Statins and Myocarditis.
- Extracorporeal Membrane Oxygenation
- Therapeutic Antibodies
- Implantable Cardioverter-Defibrillator
- Cardiac Resynchronization Therapy
- Atherosclerosis
- Myocarditis
- Cholesterol-lowering
- Cardiac Remodeling
- Cytokines
- Heart Failure
- Myocardial Infarction
- Inflammatory Response
- Statins
- Viral Infection
- Immune Response
- Fc Receptors
- Surgical Repair
- Ventricular Reconstruction
- Left Ventricular Assist Device
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Heart Failure194 topics
- Cytokines122 topics
- Myocardial Infarction112 topics
- Cardiac Remodeling81 topic
- Inflammatory Response81 topic
- Cholesterol-lowering71 topic
- Statins71 topic
- Myocarditis61 topic
- Viral Infection61 topic
- Atherosclerosis41 topic
- Immune Response41 topic
- Cardiac Resynchronization Therapy31 topic
- Fc Receptors31 topic
- Implantable Cardioverter-Defibrillator31 topic
- Surgical Repair31 topic
- Therapeutic Antibodies31 topic
- Ventricular Reconstruction31 topic
- Extracorporeal Membrane Oxygenation21 topic
- Left Ventricular Assist Device21 topic
Where does Jose H. Flores‐Arredondo work?
Jose H. Flores‐Arredondo's main affiliation in the publication record is Houston Methodist, United States.
How many publications and citations does Jose H. Flores‐Arredondo have?
OpenAlex counts 32 works and 1,100 citations for Jose H. Flores‐Arredondo, an h-index of 12, ranking #2,182,003 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jose H. Flores‐Arredondo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.